Skip to main content
SpringerLink
Log in

Economic burden of HPV substantial in Canada

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 Canadian dollars

Reference

  • Righolt CH, et al. The Direct Medical Costs of Diseases Associated with Human Papillomavirus Infection in Manitoba, Canada. Applied Health Economics and Health Policy : 4 Jan 2018. Available from: URL: http://doi.org/10.1007/s40258-017-0367-1

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Economic burden of HPV substantial in Canada. PharmacoEcon Outcomes News 795, 12 (2018). https://doi.org/10.1007/s40274-018-4650-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4650-7

Search

Navigation